![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SP3 |
Gene summary for SP3 |
![]() |
Gene information | Species | Human | Gene symbol | SP3 | Gene ID | 6670 |
Gene name | Sp3 transcription factor | |
Gene Alias | SPR2 | |
Cytomap | 2q31.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q02447 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6670 | SP3 | CA_HPV_1 | Human | Cervix | CC | 2.09e-03 | -1.60e-02 | 0.0264 |
6670 | SP3 | CCI_2 | Human | Cervix | CC | 7.96e-04 | 6.47e-01 | 0.5249 |
6670 | SP3 | CCI_3 | Human | Cervix | CC | 2.34e-05 | 7.28e-01 | 0.516 |
6670 | SP3 | L1 | Human | Cervix | CC | 7.06e-03 | -2.04e-01 | 0.0802 |
6670 | SP3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.03e-19 | -5.86e-01 | 0.0155 |
6670 | SP3 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.75e-04 | -4.03e-01 | -0.1808 |
6670 | SP3 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.90e-05 | -5.17e-01 | -0.1207 |
6670 | SP3 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.11e-02 | -4.10e-01 | -0.1526 |
6670 | SP3 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.24e-09 | -4.25e-01 | -0.1464 |
6670 | SP3 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.17e-06 | -3.82e-01 | -0.1001 |
6670 | SP3 | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.88e-03 | -3.87e-01 | -0.059 |
6670 | SP3 | HTA11_866_3004761011 | Human | Colorectum | AD | 4.34e-07 | -4.37e-01 | 0.096 |
6670 | SP3 | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.42e-02 | -5.36e-01 | 0.0528 |
6670 | SP3 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.53e-02 | -3.91e-01 | 0.0338 |
6670 | SP3 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.91e-11 | -4.57e-01 | 0.0674 |
6670 | SP3 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.80e-05 | -3.84e-01 | 0.294 |
6670 | SP3 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.30e-06 | -3.96e-01 | 0.3859 |
6670 | SP3 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.49e-02 | -4.78e-01 | 0.2585 |
6670 | SP3 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.48e-10 | -4.56e-01 | 0.3005 |
6670 | SP3 | F007 | Human | Colorectum | FAP | 3.30e-02 | -1.64e-01 | 0.1176 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003249611 | Liver | HCC | response to lipopolysaccharide | 174/7958 | 343/18723 | 1.19e-03 | 6.62e-03 | 174 |
GO:0000079 | Liver | HCC | regulation of cyclin-dependent protein serine/threonine kinase activity | 55/7958 | 94/18723 | 1.25e-03 | 6.91e-03 | 55 |
GO:1904029 | Liver | HCC | regulation of cyclin-dependent protein kinase activity | 57/7958 | 98/18723 | 1.26e-03 | 6.92e-03 | 57 |
GO:00705361 | Liver | HCC | protein K63-linked deubiquitination | 24/7958 | 35/18723 | 1.64e-03 | 8.61e-03 | 24 |
GO:19011844 | Liver | HCC | regulation of ERBB signaling pathway | 47/7958 | 79/18723 | 1.71e-03 | 8.91e-03 | 47 |
GO:003287222 | Liver | HCC | regulation of stress-activated MAPK cascade | 102/7958 | 192/18723 | 1.86e-03 | 9.49e-03 | 102 |
GO:004205922 | Liver | HCC | negative regulation of epidermal growth factor receptor signaling pathway | 20/7958 | 28/18723 | 1.86e-03 | 9.50e-03 | 20 |
GO:0016578 | Liver | HCC | histone deubiquitination | 17/7958 | 23/18723 | 2.28e-03 | 1.13e-02 | 17 |
GO:000223711 | Liver | HCC | response to molecule of bacterial origin | 181/7958 | 363/18723 | 2.58e-03 | 1.24e-02 | 181 |
GO:00219154 | Liver | HCC | neural tube development | 82/7958 | 152/18723 | 2.83e-03 | 1.33e-02 | 82 |
GO:00093146 | Liver | HCC | response to radiation | 223/7958 | 456/18723 | 3.08e-03 | 1.43e-02 | 223 |
GO:000725412 | Liver | HCC | JNK cascade | 89/7958 | 167/18723 | 3.09e-03 | 1.44e-02 | 89 |
GO:00463291 | Liver | HCC | negative regulation of JNK cascade | 25/7958 | 38/18723 | 3.18e-03 | 1.47e-02 | 25 |
GO:00420584 | Liver | HCC | regulation of epidermal growth factor receptor signaling pathway | 43/7958 | 73/18723 | 3.43e-03 | 1.55e-02 | 43 |
GO:000024511 | Liver | HCC | spliceosomal complex assembly | 46/7958 | 79/18723 | 3.45e-03 | 1.56e-02 | 46 |
GO:0071901 | Liver | HCC | negative regulation of protein serine/threonine kinase activity | 66/7958 | 120/18723 | 3.81e-03 | 1.68e-02 | 66 |
GO:003032311 | Liver | HCC | respiratory tube development | 95/7958 | 181/18723 | 4.15e-03 | 1.81e-02 | 95 |
GO:00711081 | Liver | HCC | protein K48-linked deubiquitination | 23/7958 | 35/18723 | 4.72e-03 | 2.02e-02 | 23 |
GO:00018384 | Liver | HCC | embryonic epithelial tube formation | 66/7958 | 121/18723 | 4.94e-03 | 2.07e-02 | 66 |
GO:0097194 | Liver | HCC | execution phase of apoptosis | 48/7958 | 85/18723 | 6.47e-03 | 2.63e-02 | 48 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SP3 | SNV | Missense_Mutation | c.1030N>A | p.Asp344Asn | p.D344N | Q02447 | protein_coding | tolerated(0.18) | benign(0.011) | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SP3 | SNV | Missense_Mutation | c.2128N>T | p.His710Tyr | p.H710Y | Q02447 | protein_coding | tolerated(0.82) | possibly_damaging(0.579) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD | |
SP3 | SNV | Missense_Mutation | c.518T>G | p.Ile173Arg | p.I173R | Q02447 | protein_coding | deleterious(0) | probably_damaging(0.956) | TCGA-B6-A0I9-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
SP3 | SNV | Missense_Mutation | c.2066N>A | p.Arg689His | p.R689H | Q02447 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-D8-A142-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamid | SD | |
SP3 | SNV | Missense_Mutation | novel | c.1996G>T | p.Asp666Tyr | p.D666Y | Q02447 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-E9-A245-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
SP3 | insertion | Frame_Shift_Ins | novel | c.1023_1024insTT | p.Thr342LeufsTer3 | p.T342Lfs*3 | Q02447 | protein_coding | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
SP3 | SNV | Missense_Mutation | novel | c.2324C>T | p.Ser775Phe | p.S775F | Q02447 | protein_coding | deleterious(0.01) | probably_damaging(0.915) | TCGA-C5-A1MN-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
SP3 | SNV | Missense_Mutation | rs761430393 | c.2165N>T | p.Ala722Val | p.A722V | Q02447 | protein_coding | tolerated(0.26) | benign(0) | TCGA-LP-A4AU-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
SP3 | SNV | Missense_Mutation | novel | c.1985T>G | p.Phe662Cys | p.F662C | Q02447 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SP3 | SNV | Missense_Mutation | novel | c.706N>T | p.Val236Phe | p.V236F | Q02447 | protein_coding | deleterious(0) | benign(0.383) | TCGA-AA-A01K-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6670 | SP3 | TRANSCRIPTION FACTOR | DOXORUBICIN | DOXORUBICIN | 17511886 |
Page: 1 |